SCHEMBL1735914

SCHEMBL1735914

Cc1c(C)n(Cc2ccccc2)c2c(NCc3ccc(F)cc3)nc(C(N)=O)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
HTT P42858 1/20 0.46
GRM2 Q14416 4/20 0.43
TP53 P04637 1/20 0.43
PPARG P37231 2/20 0.42
APP P05067 1/20 0.42
FABP4 P15090 1/20 0.42
MDM2 Q00987 1/20 0.42
ABL1 P00519 1/20 0.41
FYN P06241 1/20 0.41
SRC P12931 1/20 0.41
FLT3 P36888 1/20 0.41
KCNH2 Q12809 2/20 0.41
ENPP2 Q13822 1/20 0.41
TSHR P16473 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
AURKA O14965 1/20 0.40
RPS6KB1 P23443 1/20 0.40
USP2 O75604 1/20 0.40
F2 P00734 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1736968 0.99 MAPT (0.45) MAPTHTTGRM2TP53PPARG
SCHEMBL1738141 0.92 MAPT (0.47) MAPTHTTTP53PPARGAPP
Hydrochloric Acid SCHEMBL1736991 0.91 MAPT (0.46) MAPTHTTTP53PPARGAPP
Hydrochloric Acid SCHEMBL1738844 0.85 MEN1 (0.43) MAPTHTTKMT2A
SCHEMBL27698535 0.85 CTNNB1 (0.44) MAPTHTTTP53KMT2A
SCHEMBL3842414 0.84 MAPT (0.49) MAPTHTTKMT2A
Hydrochloric Acid SCHEMBL1737509 0.84 CTNNB1 (0.44) MAPTHTTTP53KMT2A
Hydrochloric Acid SCHEMBL1736846 0.84 MAPT (0.49) MAPTHTTKMT2A
Hydrochloric Acid SCHEMBL1737355 0.83 TP53 (0.46) MAPTHTTTP53PPARGAPP
Hydrochloric Acid SCHEMBL1737083 0.83 MEN1 (0.51) MAPTHTTTP53KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188114-B2 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2012-05-29 US disclosed
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP disclosed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US disclosed
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2010-03-18 US disclosed
US-7662832-B2 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-02-16 US disclosed
EP-1784404-A4 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2009-09-09 EP disclosed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US disclosed
EP-1784404-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Yuhan Corporation (KR) 2007-05-16 EP disclosed
WO-2006025716-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2006-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H MAPT 3920/4885HTT 877/4885GRM2 3507/4885
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H MAPT 3920/4885HTT 877/4885GRM2 3507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.